Rick Buck’s Post

Understanding inequities within our communities lead to a better understanding of inequities within health and healthcare. Cancer is no exception. As a cancer survivor myself, I understand the importance of this research. Take a minute to read and see how you can make an impact on changing the landscape. #socialdeterminantsofhealth #cancerdisparities #inequitiesinhealth #cancerreaseach

The AACR Cancer Disparities Progress Report 2024 is now available. The report outlines the complex socioeconomic, cultural, environmental, and biological factors that drive and perpetuate cancer health disparities and calls for a multidisciplinary and collaborative approach—including robust federal funding—to achieve health equity. Read the report: https://bit.ly/3ylI8JM #CancerDisparitiesReport #healthequity

Our National Cancer Policy Forum will host a workshop and poster session on March 20-21 to examine the complex interactions among biological variables and social determinants of health (SDOH) and how these factors interact to affect cancer-related health outcomes. Learn more and register here: https://ow.ly/IYJl50Qtm6M #NatlCancerForum #SDOH #CancerRisk

Our National Cancer Policy Forum will host a workshop and poster session on March 20-21 to examine the complex interactions among biological variables and social determinants of health (SDOH) and how these factors interact to affect cancer-related health outcomes. Learn more and register here: https://ow.ly/WkCb50Qtm9x #NatlCancerForum #SDOH #CancerRisk

Our National Cancer Policy Forum will host a workshop and poster session on March 20-21 to examine the complex interactions among biological variables and social determinants of health (SDOH) and how these factors interact to affect cancer-related health outcomes. Learn more and register here: https://ow.ly/3Tft50Qtm8t #NatlCancerForum #SDOH #CancerRisk

Our National Cancer Policy Forum will host a workshop and poster session on March 20-21 to examine the complex interactions among biological variables and social determinants of health (SDOH) and how these factors interact to affect cancer-related health outcomes. Learn more and register here: https://ow.ly/wENB50Qtm7H #NatlCancerForum #SDOH #CancerRisk

WHO Labels Talc as 'Probably Carcinogenic' for Humans! It's crucial to discuss emerging health concerns. The WHO's IARC - International Agency for Research on Cancer / World Health Organization has classified talc as "probably carcinogenic" to humans, particularly concerning its potential link to ovarian cancer with genital use. Ongoing research is investigating the safety of talcum powder due to concerns about possible asbestos contamination. While a definite link has not been established, it's crucial for healthcare providers to discuss the risks and benefits with patients. This ensures patients can make informed decisions that prioritize their health. #publichealth #healthcarenews #cancerawareness

Examining health-related quality of life (HRQoL) may predict subsequent health care resource utilization (HCRU) in patients with active cancer. Learn how associations between QM's SF-12v2 health scores and subsequent HCRU can help guide the evaluation of therapies and health policies: https://lnkd.in/g4aThKQF #WorldCancerDay #patientjourney #CancerResearch

The Community Preventive Services Task Force (CPSTF) recommends patient navigation services to increase breast, cervical, and colorectal cancer screenings among historically disadvantaged racial and ethnic populations and people with lower incomes. Patient navigation services are expected to advance health equity when implemented among these populations with lower screening rates. Learn more: bit.ly/CPSTF-AHE.

Medically unnecessary. A colleague recently picked up a very early-stage colon cancer on a patient and said that if it weren't for her vigilance, this cancer would have been missed. Perhaps. But perhaps this local malignancy would have lost its local blood supply and disappeared or grown so slowly that it would have never caused any issues. The number of colonoscopies she's done on any patient with any GI complaints is staggering. What's the benefit of harm vs risk? There are 2 answers here; on the individual level it might seem that every screening test and intervention is worth doing. On the population level, it's a matter of cost and balancing access. I'm not a public health expert, so I'll leave pop health alone. On the individual level, catching something early doesn't necessarily mean a better overall outcome. Each test has a risk, even a blood test. From false positives to anxiety and stress from waiting for results to biopsy complications ... everything has to be weighed.